OPIOID DEPENDENCY
DETOX

S.T. Genesis is an FDA-cleared Percutaneous Nerve Field Stimulator (PNFS) that supports a patient’s reduction of opioid withdrawal symptoms. Stimulation is performed by sending electrical pulses emitted through needles strategically positioned in the ear to branches of cranial nerves V, VII, IX, and X as well as the occipital nerves.

Dr. Michelle Weiner is providing patients with opioid dependency a non-invasive, direct route to get back to their life before opioids.


It is time to break free from the cycle of opioid dependency and regain your life!

FAQ’s about Opioid Dependency Detoxing

  • Patients with visible withdrawal symptoms (such as sweating, increased pulse rate, dilated pupils, nausea, vomiting) and those who measure with mild to severe withdrawal symptoms on the Clinical Opiate Withdrawal Scale (COWS) score.

  • S.T. Genesis is an FDA-cleared Percutaneous Nerve Field Stimulator (PNFS) that supports a patient’s reduction of opioid withdrawal symptoms. Stimulation is performed by sending electrical pulses emitted through needles strategically positioned in the ear to branches of cranial nerves V, VII, IX, and X as well as the occipital nerves.

  • Speranza, the manufacturer of S.T. Genesis Treatment understands the difficulties in navigating the pathways to insurance reimbursement within the neuromodulation industry. That’s why they have created a separate division called Reimbursement Support Services. This division has been built with the patient and provider in mind to create seamless options to reimbursement and to ease the burden of obtaining proper reimbursement for the neuromodulation patient.

    For assistance with the program forms or referral submission, please contact Speranza Support at 1-866-923-0710.

Why Cannabis? The Endocannabinoid System

Your body makes naturally occurring cannabinoids and is biologically equipped with cannabinoid receptors. This network of receptors found throughout the brain and body, plus our naturally occurring cannabinoids and specific enzymes makes up the ECS. Cannabis consists of more than 400 substances, including 140 cannabinoids such as THC, CBD, CBN, CBG, THCA, terpenes, and flavonoids. Cannabinoids, including CBD and THC, interact with your body’s endocannabinoid system, or ECS. The ECS is a system of receptors found in all mammals. These receptors, CB1 and 2, are located in the brain and nervous system throughout the body. The coolest part? Everyone’s endocannabinoid system is a little different, which is why personalizing the cannabis experience for each user is so important for the most beneficial results.

Take the guesswork out of finding the right CBD or cannabinoid product for you with a DNA test that matches you with the right cannabinoid products for your endocannabinoid system.

Observational Study of Opioid and Cannabis Use Among Chronic Pain Patients in Florida

Weiner, M DO MPH, Madhivinana, P MD PhD, Chavez, D. (pending publication, IRB approved)

Cannabis as a Substitute For Opioids in Chronic Pain: In Florida, there are more than 400,000 medical marijuana card holders and chronic non-malignant pain is the number one qualifying condition, accounting for nearly 34% of diagnoses at certified dispensaries (FL. Weekly Updates Oct 4 2019).

In the US, 200 million opioid prescriptions are written every year and more than 130 people die every day from opioid overuse which has quadrupled since 1999, a 200% increase. Seventy-two billion dollars is spent in medical costs each year in the US for opioid abuse. The International Journal of Drug policy published that 30% use Cannabis as a substitute for opioids.

CHECK BACK FOR FUTURE PUBLICATION

RESEARCH & READING

RESEARCH & READING

Clinical Endocannabinoid Deficiency Syndrom (CED) - by Dr. Weiner in HighLife

The theory of Clinical Endocannabinoid Deficiency (CED) is based on the concept that many brain disorders are associated with neurotransmitter deficiencies.

READ

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (British Journal of Pharmacology)

Explores the therapeutic potential of cannabis terpenoids - including limonene, myrcene, and caryophyllene - and their synergistic interactions with phytocannabinoids.

READ (PDF)

The Microbiome, Gut-Brain Axis, and Cannabis

This article proposes the theory of clinical endocannabinoid deficiency (CED) to explain common subjective pain conditions like migraine, fibromyalgia, and irritable bowel syndrome.

READ

Eat Fat or Oil before Cannabis Use for a Faster Onset

High-fat meal significantly increased THC and 11-OH-THC blood levels and prolonged their effects compared to a fasted state, while 5 mg THC produced higher peak THC levels in females versus males when fasted but was otherwise safe and well-tolerated.

READ

700 Medical Cannabis Studies, sorted by Disease

Here is a collection of clinical studies, papers and references providing the ultimate resource for medical disorders helped by cannabis.

READ

A Retrospective Medical Record Review of Adults with Non-Cancer Diagnoses Prescribed Medicinal Cannabis

The findings of this study suggest that a balanced formulation of medicinal cannabis is safe and effective in treating older patients, with treatment-resistant neurological conditions seeing the most benefits.

READ

"The body doesn’t know the difference between an experience and a thought, you can literally change your biology, neuro-circuitry, chemistry, hormones, and genes by simply having an inner experience"

Dr. Joe Dispenza